CD1c/BDCA-1 Antibody (M241) [DyLight 594]
Novus Biologicals, part of Bio-Techne | Catalog # NB100-2645DL594
Clone M241 was used by HLDA to establish CD designation.
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry, Immunoprecipitation, Radioimmunoassay
Label
DyLight 594 (Excitation = 593 nm, Emission = 618 nm)
Antibody Source
Monoclonal Mouse IgG1 Clone # M241
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
MOLT 4 cell line
Localization
Cell Membrane
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for CD1c/BDCA-1 Antibody (M241) [DyLight 594]
Application
Recommended Usage
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Radioimmunoassay
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CD1c/BDCA-1
Alternate Names
BDCA-1, BDCA1, CD1c, R7
Gene Symbol
CD1C
Additional CD1c/BDCA-1 Products
Product Documents for CD1c/BDCA-1 Antibody (M241) [DyLight 594]
Product Specific Notices for CD1c/BDCA-1 Antibody (M241) [DyLight 594]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...